wsj
Sarepta’s treatment for Duchenne muscular dystrophy should become a blockbuster next year.
As private-equity-owned companies default, lenders are resorting to measures that seem extreme.
There is still a lot to like about the beauty retailer, which has been in the bargain bin since admitting that competitive threats were slowing down i
Payment companies and banks might be able to vie for more digital checkouts in stores.
It’s not just leasing your car. Christmas trees, camping gear and even caskets are up for rent.
The Score is a weekly review of the biggest stock moves and the news that drove them.
A streak of encouraging economic reports buoys markets; H&R Block stock a standout.
Continuous gold futures on the New York Mercantile Exchange reached as high as $2,538.7 earlier in the session, breaking the prior record of $2,522.5.
Companies backed by firms are taking on more risky debt to pay dividends to investors.
Big pharma emerged relatively unscathed from Medicare price negotiations, but that might not always be the case.
The market’s upbeat reaction to Scotiabank’s purchase of a stake in the Cleveland-based lender is an eyebrow-raising indicator.
Three popular stock market valuation tools are saying the rebound of the past couple of weeks is a fools’ rally.
Americans have more options than ever to shelter their investments from taxes. Here’s how to make smart use of five major types of accounts.
His firm’s performance is helping win a war of styles in its corner of professional investing.
Ulta Beauty shares jump after Berkshire Hathaway discloses a small stake; Walmart reports strong sales.
The retailer is now the S&P 500’s best-performing retail stock in 2024—and with good reason.
Mars’s nearly $30 billion deal to buy Pringles maker Kellanova would push the candy company into the chips and cracker aisles and hand it more of th
Walmart earnings and retail sales on Thursday will offer more clues on the economy.
Commercial crude oil stocks rose by 1.4 million barrels in the latest week, contrary to analysts’ expectations for a fall, but remain about 5% below
The privately held Mars is expected to pay $83.50 per share for Kellanova in the all-cash deal.
